肝细胞癌（HCC）约占肝癌病例的 80% 至 ...

Discover a study validating the TRIUMPH machine learning model, which improves prediction of post-transplant recurrence in ...

Researchers validated the system using tissue samples from 231 patients across five hospitals. Further validation studies are ...

Corina Dutcus, SVP, oncology global clinical development lead, Eisai, highlights how consistent survival data from the LEAP-002 study reaffirms lenvatinib’s value in first-line treatment of ...

Corina Dutcus, SVP, oncology global clinical development lead at Eisai, discusses the potential of the E7386 and lenvatinib ...

Singaporean researchers have developed an artificial intelligence-powered scoring system capable of predicting the recurrence ...

Summit Therapeutics' leading candidate is showing promise in a key oncology market. Three years ago, Summit Therapeutics ...

Researchers find that disrupted circadian rhythms may impair gut regeneration and microbiome balance, heightening colon ...

Cambridge-based biotech spinout Spliceor has secured investment from the Cell and Gene Therapy Catapult (CGT Catapult) to ...

Singaporean researchers have unveiled a new artificial intelligence-based scoring tool designed to predict the recurrence of ...

Meta-analysis reveals that antiplatelet drugs may curb liver-related complications, including malignancy and thrombosis.